Comparison of Gluteal Muscle Activation and Core Strengthening in Dead Butt Syndrome Syndrome

May 4, 2026 updated by: Riphah International University

Comparison of Gluteal Muscle Activation and Core Strengthening in Dead Butt Syndrome

The study design would be a Randomized Controlled Trial.This study would include a total 40 participants. 20 participants in each group. Sample size is obtained through G-power. The study duration will be 12 months after the approval from the research board. Non-probability convenience sampling will be used. Randomization will be done through sealed envelope method. The study will be conducted from Quaid-e-Azam Hospital Rawalpindi and Margalla Rehabilitation Centre.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Symptoms persisting for more than 6 weeks (subacute or chronic cases).
  • Sedentary to moderately active individuals (i.e., not involved in heavy gluteal-strengthening or core training for at least 3 months prior to the study). vParticipants will be diagnosed with Dead Butt Syndrome based on the presence of at least two out of three of the following criteria:
  • Self-reported dull ache, discomfort, or tightness in the gluteal region worsened with prolonged sitting or walking.
  • Positive Trendelenburg Test
  • ≤ 4/5 on the standard MRC grading scale

Exclusion Criteria:

  • Pregnancy or plans to become pregnant during the study period.
  • Diagnosed hip labral tears, piriformis syndrome, or sciatica unrelated to gluteal amnesia.
  • Degenerative or neurological conditions such as osteoarthritis, multiple sclerosis, stroke, or spinal cord injury.
  • History of significant spinal trauma or surgery in the past 12 months.
  • Engagement in regular physical exercise or participation in rehabilitation programs within the last 6 months.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Group A: Gluteal Activation
Other: Group A: Gluteal Muscle Activation
Gluteal Activation focuses on "waking up" and isolating the gluteus maximus, medius, and minimus to ensure they fire properly, often using low-load, high-control movements.
Active Comparator: Active comparator
Group B - Gluteal Muscle Activation Program + Core Strengthening Program Hot pack applied to lumbar area for 15-20 minutes. 3 sessions per week for 4 weeks. Moderate intensity, bodyweight-based exercises with controlled movement. Each exercise: 3 sets of 15 repetitions with 30-40 seconds rest between sets. Target: Gluteal muscles and pelvic control:
Other: Group B: Gluteal Muscle Activation and Core stregthening exercises
Gluteal Activation focuses on "waking up" and isolating the gluteus maximus, medius, and minimus to ensure they fire properly, often using low-load, high-control movements.Core Strengthening focuses on stabilizing the spine and pelvis by targeting the abdominals, back, and deep pelvic muscles.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Tampa Scale of Kinesiophobia (TSK-11)
Time Frame: 4 weeks
The Tampa Scale for Kinesiophobia (TSK-11) is a shortened, 11-item version of the original 17-item TSK questionnaire used to assess fear of movement, or kinesiophobia, in individuals with chronic pain or other conditions involving movement limitations
4 weeks
Lower Extremity Functional Scale (LEFS)
Time Frame: 4 weeks
The Lower Extremity Functional Scale (LEFS) is used to assess "patients' initial function, ongoing progress, and outcome" for a variety of disorders affecting the lower extremities. LEFS is a self-reported survey. The LEFS total score ranges from 0 to 80, with higher scores indicating better functional ability.
4 weeks
Numeric Pain Rating Scale
Time Frame: 4 Weeks
The Numeric Pain Rating Scale (NPRS) is a tool used to measure the intensity of pain. It's a unidimensional scale, typically an 11-point scale ranging from 0 to 10, where 0 represents no pain and 10 represents the worst pain imaginable. Patients verbally or numerically indicate the level of pain they are experiencing.
4 Weeks
The Trendelenburg test
Time Frame: 4 Weeks
The Trendelenburg test is a physical examination used to assess the strength of hip abductor muscles, specifically the gluteus medius and gluteus minimus, or to check for the competency of venous valves in the legs. A positive Trendelenburg sign, indicated by a drop of the pelvis on the unsupported side during a single-leg stance, suggests weakness in the hip abductors.
4 Weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Riphah International University

Investigators

  • Principal Investigator: Attiq Ur Rehman, MS, Riphah International University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 5, 2025

Primary Completion (Estimated)

May 5, 2026

Study Completion (Estimated)

May 28, 2026

Study Registration Dates

First Submitted

May 4, 2026

First Submitted That Met QC Criteria

May 4, 2026

First Posted (Actual)

May 8, 2026

Study Record Updates

Last Update Posted (Actual)

May 8, 2026

Last Update Submitted That Met QC Criteria

May 4, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • REC/02289 Rehmat

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Syndrome

Clinical Trials on Group A: Gluteal Muscle Activation

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Norway

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe